German (DAX) Clinical Research and Equipment Industry Analysis

UpdatedFeb 05, 2026

DataAggregated Company Financials

Companies6

7D-2.7%
3M3.9%
1Y-19.0%
YTDn/a

Over the last 7 days, the Clinical Research and Equipment industry has dropped 1.1%, driven by a pullback from Gerresheimer of 4.2%. However, the industry is down 16% over the past year. Looking forward, earnings are forecast to grow by 25% annually.

Industry Valuation and Performance

Has the German Clinical Research and Equipment Industry valuation changed over the past few years?

Date	Market Cap	Revenue	Earnings	PE	Absolute PE	PS
Thu, 05 Feb 2026	€19.2b	€7.5b	€143.5m	37x	134x	2.6x
Sat, 03 Jan 2026	€19.5b	€7.5b	€143.5m	41.1x	136x	2.6x
Mon, 01 Dec 2025	€20.3b	€7.5b	€143.9m	39.3x	140.9x	2.7x
Wed, 29 Oct 2025	€20.0b	€7.5b	€147.4m	42x	136x	2.7x
Fri, 26 Sep 2025	€17.8b	€7.4b	€157.8m	21.7x	113x	2.4x
Sun, 24 Aug 2025	€18.6b	€7.4b	€157.8m	25.1x	118.2x	2.5x
Tue, 22 Jul 2025	€19.7b	€7.4b	€99.5m	25.9x	198.2x	2.7x
Thu, 19 Jun 2025	€20.1b	€7.3b	€114.9m	28.5x	175.1x	2.8x
Sat, 17 May 2025	€21.7b	€7.3b	€114.9m	26.4x	188.5x	3x
Mon, 14 Apr 2025	€17.7b	€7.2b	€125.5m	24.8x	141x	2.5x
Wed, 12 Mar 2025	€21.7b	€7.1b	€156.5m	27.1x	138.4x	3x
Fri, 07 Feb 2025	€23.6b	€7.1b	€169.8m	24.1x	139x	3.3x
Sun, 05 Jan 2025	€20.8b	€7.1b	€169.8m	24.5x	122.2x	2.9x
Tue, 03 Dec 2024	€22.1b	€7.1b	€170.5m	27x	129.7x	3.1x
Thu, 31 Oct 2024	€23.2b	€7.1b	€171.2m	30.2x	135.3x	3.3x
Sat, 28 Sep 2024	€24.9b	€7.1b	€172.8m	31.1x	144.2x	3.5x
Mon, 26 Aug 2024	€23.8b	€7.0b	€157.1m	34.2x	151.6x	3.4x
Wed, 24 Jul 2024	€23.7b	€7.0b	€237.1m	36.3x	100x	3.4x
Fri, 21 Jun 2024	€22.5b	€7.0b	€333.3m	28.5x	67.5x	3.2x
Sun, 19 May 2024	€26.6b	€7.0b	€340.1m	30x	78.2x	3.8x
Tue, 16 Apr 2024	€32.6b	€7.1b	€385.4m	36.8x	84.5x	4.6x
Thu, 14 Mar 2024	€33.8b	€7.1b	€384.5m	37.7x	87.9x	4.8x
Sat, 10 Feb 2024	€32.6b	€7.3b	€516.3m	38.1x	63.2x	4.5x
Mon, 08 Jan 2024	€30.8b	€7.3b	€507.1m	34.8x	60.7x	4.2x
Wed, 06 Dec 2023	€28.0b	€7.3b	€507.1m	30.4x	55.2x	3.8x
Fri, 03 Nov 2023	€25.7b	€6.4b	€356.1m	38.3x	72.1x	4x
Sun, 01 Oct 2023	€26.8b	€6.6b	€498.1m	38.3x	53.8x	4.1x
Tue, 29 Aug 2023	€29.5b	€6.6b	€425.8m	43x	69.3x	4.5x
Thu, 27 Jul 2023	€30.1b	€6.6b	€425.8m	42.1x	70.7x	4.6x
Sat, 24 Jun 2023	€26.8b	€6.7b	€487.3m	38x	55.1x	4x
Mon, 22 May 2023	€28.1b	€6.7b	€487.3m	38.6x	57.7x	4.2x
Wed, 19 Apr 2023	€30.3b	€6.8b	€595.6m	34.2x	50.8x	4.5x
Fri, 17 Mar 2023	€30.4b	€6.7b	€594.3m	34.7x	51.2x	4.5x
Sun, 12 Feb 2023	€32.5b	€6.5b	€447.4m	40.4x	72.7x	5x

Price to Earnings Ratio

72.7x

Sun, 12 Feb 2023

Current Industry PE

Investors are optimistic on the German Life Sciences Tools and Services industry, and appear confident in long term growth rates.

The industry is trading at a PE ratio of 138x which is higher than its 3-year average PE of 105x.

The 3-year average PS ratio of 3.5x is higher than the industry's current PS ratio of 2.6x.

Past Earnings Growth

The earnings for companies in the Life Sciences Tools and Services industry have declined 32% per year over the last three years.
Meanwhile revenues for these companies have grown 5.2% per year.
This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.